Revenue ($USD) : $1,557,666,000
R&D spend : $101,193,000.00
Employees : 3,722
Fiscal year end : 12/31/22
CEO : Jan De Witte
The company has since expanded its regenerative technology product portfolio to include surgical instruments, neurosurgical devices and advanced wound products.
Its brands include AmnioExcel, Aurora, Bactiseal, BioD, CerebroFlo, CereLink Certas Plus, Codman, CUSA, Cytal, DuraGen, DuraSeal, DuraSorb, Gentrix, ICP Express, Integra, Licox, Mayfield, MediHoney, MicroFrance, MicroMatrix, NeuraGen, NeuraWrap, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. –JH, DK and CN